Private clinics
- Premium therapy pathway for complex wounds
- Fewer dressing changes and nursing workload
- Launch support from the manufacturer
Collagen-laminin matrix for complex and chronic wounds with clinical applicability and a clear application protocol.
Clinically proven effect and a clear protocol without overloading staff.
Clinically proven
Accelerates epithelialization by 30–50% and heals without coarse scars
Beneficial for hospitals
Speeds treatment and increases bed turnover
Versatile
Treats complex wounds, trophic ulcers, grade II–III burns, and pressure sores


Novoskin delivers distinct value across B2B and public-sector channels—from hospitals to pharmacies, distributors, and physicians.
Modern sterile wound dressing based on a collagen-laminin matrix.
Suitable for burns, trophic ulcers, pressure sores, post-traumatic and chronic wounds.
This helps accelerate healing and improve tissue recovery quality.
For grade I–III burns, surgical and chronic wounds, pressure injuries, trophic ulcers, and soft-tissue defects.
Full biodegradation of the dressing typically occurs in 6–10 days when the protocol is followed.
Used during cleansing and preparation for healing, and at the final wound-closure stage.
For grade I–III burns, surgical and chronic wounds, pressure injuries, and trophic ulcers.
Full biodegradation of the dressing typically occurs in 6–10 days when the protocol is followed.
Used during the healing phase—helps skin recover faster, often without grafting.
Novoskin is not just a product — it is the result of years of research and development.
Novoskin successfully completed clinical trials on 3,680+ patients
Novoskin is patented in state registries of Russia, Germany, China, and the USA
Novoskin was created by biotechnologists at Sheneskin, Diagroup (Ulan-Ude)
Novoskin was developed with support from Russia's leading innovation fund
How treatment works and why a professional approach matters
A surgeon at the clinic secures Novoskin for 6–10 days — you recover comfortably at home between dressing changes. For bedridden patients, a home visit is possible. Treatment duration depends on the case.
Only a physician can properly and sterilely prepare the wound, remove necrosis, prevent infection risk, and secure the bandage reliably. Professional dressing changes are key to fast healing.
in clinical trials and evaluations in hospitals and clinics
Even when skin grafting is required, Novoskin helps restore the donor site faster — without scars and prolonged rehabilitation.
Novoskin offers a chance to avoid surgery. It is safer, more affordable, and more convenient — especially for elderly, weakened, and injured patients.
Tested in hospitals, ICUs, and palliative care units. Safe for patients with chronic conditions.
Novoskin contains no living cells and does not cause rejection reactions. Hypoallergenic composition is suitable for children, adults, and elderly patients.
Open bleeding, purulent, or infected wounds without drainage; individual intolerance to collagen and laminin.
Up to +25% revenue and –70% costs in the first month of use
Video guides, protocol templates, support at every stage
Your request was sent successfully. We will contact you shortly.
Сюжет о разработке аналога живой кожи NovoSkin и его значении для российской медицины.
Материал о том, как NovoSkin позволяет избежать пересадки кожи и сложных операций.
Новость о патентах NovoSkin в России, Китае и Германии как уникального раневого покрытия.
ТАСС Наука сообщает о начале применения покрытия NovoSkin в российских медучреждениях.
Сюжет РенТВ с пациентом, которому применили покрытие NovoSkin после ожогов.
Новость Москва24 о регистрации инновационного раневого покрытия NovoSkin.
We use cookies for site operation and analytics. By clicking "Accept", you agree to the use of cookies.
Learn more: Privacy policy